Results 1 -
10
of
58
for
IMATINIB
- ... and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med. ... Muller-Tidow C, Reiter A, Koschmieder S. Novel imatinib-sensitive PDGFRA-activating point mutations in hypereosinophilic syndrome ...
- ... and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med. ...
- ... Schultheis B, Cross NC, Goldman JM. Response to imatinib mesylate in patients with chronic myeloproliferative diseases with ...
- Chronic myeloid leukemia is a slow-growing cancer of the blood-forming tissue (bone marrow). Normal bone marrow produces red blood cells (erythrocytes) that carry ...
- The ABL1 gene provides instructions for making a protein involved in many processes in cells throughout the body. The ABL1 protein functions as a kinase, ...
- The BCR gene provides instructions for making a protein whose function is not completely understood. Studies show that the BCR protein may act as a GTPase ...
- The KIT gene provides instructions for making a member of a protein family called receptor tyrosine kinases. Receptor tyrosine kinases transmit signals from ...
- Leukemia/Treatments and Therapies ... Leukemia ... National Cancer Institute ... From the National Institutes of Health ... This page lists cancer drugs approved by the FDA ...
- Treating Chronic Myeloid Leukemia by Phase (American Cancer Society)Chronic Myeloid Leukemia/Treatments and Therapies ... Chronic Myeloid Leukemia ... American Cancer Society ... Treatment options for chronic myeloid leukemia will depend ...
- ... and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med. ... Muller-Tidow C, Reiter A, Koschmieder S. Novel imatinib-sensitive PDGFRA-activating point mutations in hypereosinophilic syndrome ...